CII
SRPT icon

Capital International Inc’s Sarepta Therapeutics SRPT Stock Holding History

Capital International Inc’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-23,148
Closed -$396K – 319
2025
Q2 		$396K Sell
23,148
-4,342
-16% -$185K ﹤0.01% 298
2025
Q1 		$1.75M Buy
27,490
+4,997
+22% +$526K 0.02% 268
2024
Q4 		$2.73M Buy
22,493
+14,822
+193% +$1.82M 0.03% 254
2024
Q3 		$958K Buy
+7,671
New +$1.06M 0.01% 283
2020
Q2 		– Sell
-300
Closed -$29K – 289
2020
Q1 		$29K Buy
+300
New +$34.3K ﹤0.01% 259

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Capital International Inc's SRPT Position: Q3 2025 in Review

Capital International Inc sold out of Sarepta Therapeutics (SRPT) in Q3 2025, closing a stake of 23,148 shares — an estimated $396K sold.

Capital International Inc first reported a position in SRPT in Q1 2020 and held it in 5 quarters. The position peaked at $2.73M in Q4 2024. 319 funds tracked by Wall St. Rank hold SRPT as of Q3 2025.

  • Capital International Inc reported no remaining Sarepta Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Capital International Inc sold 23,148 Sarepta Therapeutics shares in Q3 2025, an estimated $396K.
  • Capital International Inc first reported a position in Sarepta Therapeutics in Q1 2020 and held it in 5 quarters.
  • Capital International Inc's Sarepta Therapeutics position peaked at $2.73M in Q4 2024.
  • 319 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2025.

Based on Capital International Inc's 13F filing for Q3 2025, filed 13 Nov 2025.